Home/ Supplements/ Lysine/ Morphoderm

Morphoderm

product on market Capsule MN Morphogen Nutrition Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 23% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The profile includes L-Lysine and KeraGLO, which are associated with supporting skin and hair structural integrity. Evidence for the specific combination of Fern Extract and Astrion in this context is limited. Overall, the ingredients are generally recognized as safe, though clinical data for the full blend is sparse.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Morphoderm
Open Full PDF View on NIH DSLD →
Details

Label Data

6 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
23%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

2000 mg
Market median: 500.0mg (159 products)
KeraGLO
500 mg
Fern Extract
480 mg
Market median: 500.0mg (9 products) 7 studies — no high-quality reviews
Astrion
250 mg
Market median: 100.0mg (173 products)
Dermaval
50 mg
Verbasnol (Rehmannia glutinosa) leaf extract
50 mg
30 mg (273% DV)
2.7× RDA — within safe limits 263 studies (A:6, B:134)
20 mg
Market median: 10.0mg (35 products) 6 studies (A:0, B:2)
8 mg
Market median: 10.0mg (105 products) 2 studies (A:0, B:1)
8 mg
Market median: 4.0mg (32 products)
Market median: 4.0mg (47 products)

Other Ingredients

Gelatin Titanium Dioxide Candurin Silver Fine FD&C Blue #1 FD&C Red #40
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended use: As a dietary supplement, take 6 capsules per day in divided doses, preferably with meals. Exceeding recommended daily dosage is not advised.

Warnings & Precautions

Warnings: Not intended for use by persons under the age of 18.

If you are pregnant or nursing or taking any prescription medications, consult your health care professional before using this or any other dietary supplement product.

Contact your healthcare professional before using this or any other dietary supplement product. Immediately discontinue use and consult your doctor if any adverse reactions occur.

Keep out of reach of children.

Allergen information: This product is manufactured in a facility that processes other products which may contain soy, dairy, wheat, tree nuts, shellfish, fish, peanuts, and eggs.

Formulation Notes

Hair, Skin & Eye Health Complex Rejuvenate Nourish Protect

With: KeraGlo Dermaval supports collagen from within Astrion Verbasnol

May assist with: Healthy, nourished and supple skin and hair Reducing inflammation, bacteria growth, acne, wrinkles and sun damage Increasing collagen production; decreased collagen breakdown Increasing keratin production; stronger hair and skin Reducing hair loss and breakage UV protection and advanced skin hydration Preserving retinal health and reducing oxidative eye stress Reducing DNA damage Reducing symptoms of herpes simplex virus (cold sores, etc.) Nutrient provision for skin, hair, nails, joints, connective tissue, and eyes

Additional Information

Store in a cool, dry place and avoid excessive heat.

Morphogen Nutrition specializes in developing no BS, scientifically validated, effectively dosed and affordable sports nutrition supplements Knowledge Honesty Integrity No BS High Potency Formula Pure Ingredients Maximum Performance

Join the takeover

Manufactured in the USA for Morphogen Nutrition GMP Good Manufacturing Practice Quality Product FDA Registered Lab Tested 3rd Party Certified for Purity & Potency

Metadata

Product Details

UPC / SKU7 87790 05589 1
DSLD Entry Date2022-02-23
Product TypeOther Combinations
FormCapsule
DSLD ID261161
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.